Brief: Elicera Q3 Operating Loss Widens To SEK 6.8 Mln

Elicera Therapeutics AB

18/11/2021 08:10

Nov 18 (Reuters) - Elicera Therapeutics AB  ELIC.ST :
    * Q3 OPERATING LOSS TOTALED SEK -6,753,799 (-216,550).
    * Q3 LOSS FOR PERIOD TOTALED SEK -6,753,799 (-211,132)
    * Q3 CASH FLOW FROM OPERATING ACTIVITIES TOTALED SEK
-13,418,888
(-104,589)

Source text for Eikon:  ID:nWkr6HgJgJ 
Further company coverage:  ELIC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))